Zelira Therapeutics Ltd has released a press release.
Zelda Enters Strategic Partnership with CannPal
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- Clinical Trials to Commence in Chile
- New Licence Agreement
- Appendix 4D & FY17 Interim Financial Report
- Quarterly Report and Appendix 4C
- Zelda to Test Formulations Against Pancreatic Cancer
Later from Zelira Therapeutics
- Zelda Successfully Completes Capital Raising
- Cleansing Prospectus
- Clinical Research Programme to Expand to Include Autism
- March 2017 Quarterly Report
- Positive Results From Pre-Clinical Breast Cancer Studies
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics